Confluent and reticulated papillomatosis: A review of the literature

American Journal of Clinical Dermatology

Volumn 7, Issue 5, 2006, Pages 305-313

  Scheinfeld, Noah ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CALCIPOTRIOL; CEFDINIR; CLARITHROMYCIN; ERYTHROMYCIN; ETRETIN; ETRETINATE; FURACYCLIN; FUSIDIC ACID; ISOTRETINOIN; KETOCONAZOLE; MINOCYCLINE; RETINOIC ACID; RETINOID; ROXITHROMYCIN; SELENIUM SULFIDE; TACALCITOL; TAZAROTENE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ACANTHOSIS NIGRICANS; ACTINOMYCETALES; AGE DISTRIBUTION; AMYLOIDOSIS; ASHY DERMATOSIS; BACTERIUM; CONFLUENT AND RETICULATED PAPILLOMATOSIS; CONTACT DERMATITIS; CORYNEBACTERIACEAE; COST BENEFIT ANALYSIS; DARIER DISEASE; DERMATOPATHIA PIGMENTOSA RETICULARIS; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG HYPERSENSITIVITY; DYSCHROMATOSIS HEREDITARIA UNIVERSALIS; DYSKERATOSIS; DYSKERATOSIS CONGENITA; ENDOCRINE DISEASE; EPIDERMODYSPLASIA VERRUCIFORMIS; ERYTHROKERATODERMA FIGURATA VARIABILIS; FLAT WART; HISTOLOGY; HUMAN; HYPERKERATOSIS; LICHEN PIGMENTOSUS; LOW DRUG DOSE; MEDLINE; MYCOSIS FUNGOIDES; NEVUS; NUCLEOTIDE SEQUENCE; PAPULE; PARAKERATOSIS; PITYRIASIS RUBRA PILARIS; PITYROSPORUM; PRIORITY JOURNAL; PRURIGO; PSEUDOATROPHODERMA COLLI; RACE; REVIEW; SEBORRHEIC KERATOSIS; SEX; SKIN; SKIN DISEASE; SYRINGOMA; TINEA VERSICOLOR; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; FEMALE; MALE; PAPILLOMA;

ACANTHOSIS NIGRICANS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MINOCYCLINE; PAPILLOMA;

EID: 34347235162     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200607050-00004     Document Type: Review

References (81)

1. Gougerot H, Carteaud A. Papillomatose pigmentée innominée. Bull Soc Fr Dermatol Syphiligr 1927; 34: 719
2. Wise F, Sachs W. Cutaneous papillomatose: papillomatose confluente et reticulée. Arch Dermatol Syphilol 1937; 36: 475-85
3. Wise F. Confluent and reticular papillomatosis (Gougerot-Carteaud). Arch Dermatol Syphilol 1937; 35: 550
4. Decroix J, Bourlond A, Minet A, et al. Gougerot-Carteaud confluent and reticulated papillomatosis associated with pseudoacanthosis nigricans: the same entity? Ann Dermatol Venereol 1987; 114: 223-6
5. Watkins DB, Lockwood H. Confluent and reticulated cutaneous papillomatosis; report of a case. AMA Arch Dermatol 1957; 76: 648-51
6. Kruger H, Winkler K. Confluent and reticular papuloid papillomatosis. Z Haut Geschlechtskr 1967; 42: 249-52
7. Palomeque FE, Hairston Jr MA. Confluent and reticulated cutaneous papillomatosis. Arch Dermatol 1965; 92: 49-51
8. Watkins DB, Hoeffler DF. Confluent and reticulated cutaneous papillomatosis: report of a case and commentary. JAMA 1960; 174: 1153-6
9. Sau P, Lupton GP. Reticulated truncal pigmentation: confluent and reticulated papillomatosis of Gougerot and Carteaud. Arch Dermatol 1988; 124: 1272-5
10. Friart G, Van der Meiren L. Gougerot-Carteaud's confluent and reticulated papillomatosis. Arch Belg Dermatol Syphiligr 1957; 13: 154-5
11. Duperrat B, Gole L. A further case of Gougerot-Carteaud confluent and reticulated papillomatosis. Presse Med 1965 Jan 27; 73: 251-4
12. Bonelli M, Bubola D. Confluent and reticulated papular papillomatosis of Gougerot and Carteaud. G Ital Dermatol 1961; 102: 255-92
13. Atasoy M, Aliagaoglu C, Erdem T. A case of early onset confluent and reticulated papillomatosis with an unusual localization. J Dermatol 2006; 33: 273-7
14. Natarajan S, Milne D, Jones AL, et al. Dietzia strain X: a newly described Actinomycete isolated from confluent and reticulated papillomatosis. Br J Dermatol 2005; 153: 825
15. Davis MD, Weenig RH, Camilleri MJ. Confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis: a study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol 2006; 154: 287-93
16. Hamilton D, Tavafoghi V, Schafer JC, et al. Confluent and reticulated papillomatosis of Gougerot and Carteaud: its relation to other papillomatoses. J Am Acad Dermatol 1980; 2: 401-10
17. Becker KA, Schwartz RA. Confluent and reticulated papillomatosis [online]. Available from URL: http: //www.emedicine.com/derm/topic82.htm [Accessed 2006 Aug 30]
18. Beurey J, Vadot J, Mougeolle JM, et al. Confluent and reticulated papillomatosis of Gougerot and Carteaud associated with pityriasis versicolor. Bull Soc Fr Dermatol Syphiligr 1965; 72: 416-8
19. Duverne J, Volle H, Gogue Y, et al. Gougerot and Carteaud confluent and reticulated papillomatosis with the presence of pityriasis versicolor. Bull Soc Fr Dermatol Syphiligr 1966; 73: 335-6
20. Yesudian P, Kamalam S, Razack A. Confluent and reticulated papillomatosis (Gougerot-Carteaud): an abnormal host reaction to Malassezia furfur. Acta Dermatol Venereol 1973; 53: 381-4
21. Gupta AK, Batra R, Bluhm R, et al. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004; 51: 785-98
22. el-Tonsy MH, el-Benhawi MO, Mehregan AH. Confluent and reticulated papillo-matosis. J Am Acad Dermatol 1987; 16: 893-4
23. Hirokawa M, Matsumoto M, Iizuka H. Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated with obesity and insulin resistance. Dermatology 1994; 188: 148-51
24. Baalbaki SA, Natarajan S, Al-Khars MA. Confluent and reticulated papillomatosis: treatment with antibiotics. J Dermatol Treat 1995; 6: 13-5
25. Montemarano AD, Hengge M, Sau P, et al. Confluent and reticulated papillomatosis: response to minocycline. J Am Acad Dermatol 1996; 34: 253-6
26. Vassileva S, Pramatarov K, Popova L. Ultraviolet light-induced confluent and reticulated papillomatosis. J Am Acad Dermatol 1989; 21: 413-4
27. Groh V, Schnyder UW. Nosology of confluent and reticulated papillomatosis (Gougerot-Carteaud). Hautarzt 1983; 34: 81-6
28. Henning JP, de Wit RF. Familial occurrence of confluent and reticulated papillomatosis. Arch Dermatol 1981; 117: 809-10
29. Stein JA, Shin HT, Chang MW. Confluent and reticulated papillomatosis associated with tinea versicolor in three siblings. Pediatr Dermatol 2005; 22: 331-3
30. Schwartzberg JB, Schwartzberg HA. Response of confluent and reticulate papillomatosis of Gougerot and Carteaud to topical tretinoin. Cutis 2000; 66: 291-
31. Kagi MK, Trueb R, Wuthrich B, et al. Confluent and reticulated papillomatosis associated with atopy: successful treatment with topical urea and tretinoin. Br Dermatol 1996; 134: 381-2
32. Kumar AS, Pandhi RK. Syndrome of Carteaud and Gougerot: case report. Confluent and reticulate papillomatosis. Mykosen 1984; 27: 313-5
33. Thomsen K. Confluent and reticulated papillomatosis (Gougerot-Carteaud). Acta Derm Venereol Suppl (Stockh) 1979; 59: 185-7
34. Basak PY, Baysal V, Ozcanli C. Confluent and reticulated papillomatosis: failure of response to calcipotriol and coincidental association with vascular mottling. J Eur Acad Dermatol Venereol 2001; 15: 591-2
35. Nagy R, Fairfield JC. Confluent and reticulated papillomatosis. Cutis 1982; 29: 48-50
36. Barnette Jr DJ, Yeager JK. A progressive asymptomatic hyperpigmented papular eruption: confluent and reticulated papillomatosis (CRP) of Gougerot and Carteaud. Arch Dermatol 1993; 129: 1608-9, 1611-2
37. Hallel-Halevy D, Grunwald MH, Halevy S. Confluent and reticulated papillomatosis (Gougerot-Carteaud) of the pubic region [letter]. Acta Dermatol Venereol 1993; 73: 155
38. Palomeque FE, Hairston Jr MA. Confluent and reticulated papillomatosis of Gougerot and Carteaud. Arch Dermatol 1965; 92: 49-51
39. Abbud Neto S, di Stasi LL, Pires MC, et al. Pseudo-atrophoderma colli and Gougerot-Carteaud confluent reticulated papillomatosis (shining atrophy). Med Cutan Ibero Lat Am 1987; 15: 477-80
40. Lee MW, Goldberg LH, Dorsey K, et al. Syringoma resembling confluent and reticulated papillomatosis of Gougerot-Carteaud. Cutis 1998; 61: 227-8
41. Schnur RE, Heymann WR. Reticulate hyperpigmentation. Semin Cutan Med Surg 1997; 16: 72-80
42. Griffiths CE. Gougerot-Carteaud still an enigma after all these years. J Dermatolog Treat 2002; 13 (1): 27-30
43. Weedon D. Skin pathology: miscellaneous conditions. London: Churchill Livingstone, 2002
44. Mutasim DF. Confluent and reticulated papillomatosis without papillomatosis. J Am Acad Dermatol 2003; 49: 1182-4
45. Diez E, Alonso LM, Zambrano B, et al. Confluent and reticulated papillomatosis without papillomatosis [letter]. J Am Acad Dermatol 2005; 52: E8
46. Lee SH, Choi EH, Lee WS, et al. Confluent and reticulated papillomatosis: a clinical histopathological and electron microscopic study. J Dermatol 1991; 18: 725-30
47. Jimbow M, Talpash O, Jimbow K. Confluent and reticulated papillomatosis: clinical light and electron microscopic studies. Int J Dermatol 1992; 31: 480-3
48. Kanitakis J, Zambruno G, Viac J, et al. Involucrin expression in keratinization disorders of the skin: a preliminary study. Br J Dermatol 1987; 117: 479-86
49. Carteaud A. A case of Gougerot and Carteaud's confluent and reticulated papulous papillomatosis, completely cleared up by antibiotics. Bull Soc Fr Dermatol Syphiligr 1965; 72: 396-7
50. Chang SN, Kim SC, Lee SH, et al. Minocycline treatment for confluent and reticulated papillomatosis. Cutis 1996; 57: 454-7
51. Shimizu S, Han-Yaku H. Confluent and reticulated papillomatosis responsive to minocycline. Dermatology 1997; 194: 59-61
52. Sassolas B, Plantin P, Guillet G. Confluent and reticulated papillomatosis: treatment with minocycline. J Am Acad Dermatol 1992; 26: 501-2
53. Petit A, Evenou P, Civatte J. Confluent and reticulated papillomatosis of Gougerot and Carteaud: treatment by minocycline. Ann Dermatol Venereol 1989; 116: 29-30
54. Puig L, de Moragas JM. Confluent and reticulated papillomatosis of Gougerot and Carteaud: minocycline deserves trial before etretinate. Arch Dermatol 1995; 131: 109-10
55. Wiesenborn A, Hengge U, Megahed M. Confluent and reticulated papillomatosis: Gougerot-Carteaud disease. Hautarzt 2004; 55: 976-8
56. Jang HS, Oh CK, Cha JH, et al. Six cases of confluent and reticulated papillo-matosis alleviated by various antibiotics. J Am Acad Dermatol 2001; 44: 652-5
57. Atasoy M, Ozdemir S, Aktas A, et al. Treatment of confluent and reticulated papillomatosis with azithromycin. J Dermatol 2004; 31: 682-6
58. Ito S, Hatamochi A, Yamazaki S. A case of confluent and reticulated papillomatosis that successfully responded to roxithromycin. J Dermatol 2006; 33: 71-2
59. Michel PJ, Cretin J. A case of reticulated confluent Gougerot- and Carteaud papillomatosis cured by the treatment proposed by Carteaud (furacycline). Bull Soc Fr Dermatol Syphiligr 1969; 76: 112-3
60. Angeli-Besson C, Koeppel MC, Jacquet P, et al. Confluent and reticulated papillomatosis (Gougerot-Carteaud) treated with tetracyclines. Int J Dermatol 1995; 34: 567-9
61. Yamamoto A, Okubo Y, Oshima H, et al. Two cases of confluent and reticulate papillomatosis: successful treatments of one case with cefdinir and another with minocycline. J Dermatol 2000; 27: 598-603
62. Nordby CA, Mitchell AJ. Confluent and reticulated papillomatosis responsive to selenium sulfide. Int J Dermatol 1986; 25: 194-9
63. Friedman SJ, Albert HL. Confluent and reticulated papillomatosis of Gougerot and Carteaud: treatment with selenium sulfide lotion. J Am Acad Dermatol 1986; 14: 280-2
64. Hamaguchi T, Nagase M, Higuchi R, et al. A case of confluent and reticulated papillomatosis responsive to ketoconazole cream. Nippon Ishinkin Gakkai Zasshi 2002; 43: 95-8
65. Lee MP, Stiller MJ, McClain SA, et al. Confluent and reticulated papillomatosis: response to high-dose oral isotretinoin therapy and reassessment of epidemio-logic data. J Am Acad Dermatol 1994; 31: 327-31
66. Hodge JA, Ray MC. Confluent and reticulated papillomatosis: response to isotreti-noin [letter]. J Am Acad Dermatol 1991; 24: 654
67. Solomon BA, Laude TA. Two patients with confluent and reticulated papillomatosis: response to oral isotretinoin and 10% lactic acid lotion. J Am Acad Dermatol 1996; 35: 645-6
68. Bruynzeel-Koomen CA, de Wit RF. Confluent and reticulated papillomatosis successfully treated with the aromatic etretinate. Arch Dermatol 1984; 120: 1236-7
69. Baalbaki SA, Malak JA, al-Khars MA. Confluent and reticulated papillomatosis: treatment with etretinate. Arch Dermatol 1993; 129: 961-3
70. Bowman PH, Davis LS. Confluent and reticulated papillomatosis: response to tazarotene. J Am Acad Dermatol 2003; 48: S80-1
71. Carrozzo AM, Gatti S, Ferranti G, et al. Calcipotriol treatment of confluent and reticulated papillomatosis (Gougerot-Carteaud syndrome). J Eur Acad Dermatol Venereol 2000; 14: 131-3
72. Gulec AT, Seckin D. Confluent and reticulated papillomatosis: treatment with topical calcipotriol. Br J Dermatol 1999; 141: 1150-1
73. Kurkcuoglu N, Celebi CR. Confluent and reticulated papillomatosis: response to topical calcipotriol. Dermatology 1995; 191: 341-2
74. Yamamoto Y, Kadota M, Nishimura Y. A case of maxacalcitol-resistant confluent and reticulated papillomatosis successfully treated with minocycline. J Dermatol 2006; 33: 223-4
75. Ginarte M, Fabeiro JM, Toribio J. Confluent and reticulated papillomatosis (Gougerot-Carteaud) successfully treated with tacalcitol. J Dermatolog Treat 2002; 13: 27-30
76. Rollier E. Confluent reticulated papillomatosis of Gougerot and Carteaud. Arch Belg Dermatol Syphiligr 1958; 14: 99-101
77. Fontaine A, Wellens W. A case of Gougerot and Carteaud's confluent and reticulated papillomatosis. Arch Belg Dermatol Syphiligr 1958; 14: 232-6
78. Young AW. Cutaneous papillomatosis; confluent and reticulated variety. AMA Arch Dermatol Syphilol 1953; 67: 594-7
79. Gruber F, Zamolo G, Saftic M, et al. Treatment of confluent and reticulated papillomatosis with azithromycin [letter]. Clin Exp Dermatol 1998; 23: 191
80. Ekmekci TR, Altunay IK, Koslu A. Prurigo pigmentosa treated with doxycycline. Dermatol Online J 2006; 12 (1): 9
81. Cannavo SP, Guarneri C, Borgia F, et al. Confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl: two distinct pathologies with a common pathogenetic pathway or a unique entity dependent on insulin resistance? J Eur Acad Dermatol Venereol 2006; 20: 478-80